Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection. We describe the identification, SAR, and pharmacology of the src-family selective lck inhibitor A-770041 that prolongs the survival of major histocompatibility mismatched allografts in models of solid organ transplant rejection for greater than 65 days. 